Literature DB >> 18256364

TLR4 links podocytes with the innate immune system to mediate glomerular injury.

Miriam C Banas1, Bernhard Banas, Kelly L Hudkins, Tomasz A Wietecha, Masayuki Iyoda, Elisabeth Bock, Peter Hauser, Jeffrey W Pippin, Stuart J Shankland, Kelly D Smith, Benjamin Stoelcker, Gang Liu, Hermann-Josef Gröne, Bernhard K Krämer, Charles E Alpers.   

Abstract

Toll-like receptors (TLR) classically recognize pathogen-associated danger signals but are also activated via endogenous ligands. For evaluation of their role in inflammatory kidney disease, the function of TLR was analyzed in two mouse models of cryoglobulinemic membranoproliferative glomerulonephritis (MPGN; mice transgenic for thymic stromal lymphopoietin [TSLP], with or without deletion of the Fcgamma receptor IIb). Expression of TLR1 through 9 and TLR11 mRNA was detectable in whole kidneys and in isolated glomeruli of wild-type mice, with TLR3 and TLR4 having the highest absolute levels of expression. TLR1, 2, and 4 were increased in TSLP transgenic mice and even higher in TSLP transgenic FcgammaRIIb-deficient mice. TLR5 through 9 and 11 were upregulated to similar degrees in TSLP transgenic and TSLP transgenic FcgammaRIIb-deficient mice. Immunohistochemical studies of nephritic glomeruli localized TLR4 protein to podocytes. Cultured podocytes also expressed TLR4, and stimulation with TLR4-specific ligands resulted in a marked induction of chemokines; this was reduced by specific knockdown of TLR4 with siRNA. Fibrinogen, a potential endogenous TLR4 ligand, was shown to induce a similar profile of chemokines. In conclusion, it was demonstrated that TLR4 is constitutively expressed by podocytes and is upregulated in MPGN, where it may mediate glomerular injury by modulating expression of chemokines; therefore, TLR4 may link podocytes with the innate immune system to mediate MPGN triggered by the deposition of immune complexes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18256364      PMCID: PMC2390962          DOI: 10.1681/ASN.2007040395

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  36 in total

Review 1.  Lipopolysaccharide endotoxins.

Authors:  Christian R H Raetz; Chris Whitfield
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

2.  In vivo expression of Toll-like receptor 2 and 4 by renal epithelial cells: IFN-gamma and TNF-alpha mediated up-regulation during inflammation.

Authors:  Tim G A M Wolfs; Wim A Buurman; Annemarie van Schadewijk; Bart de Vries; Marc A R C Daemen; Pieter S Hiemstra; Cornelis van 't Veer
Journal:  J Immunol       Date:  2002-02-01       Impact factor: 5.422

3.  Cryoglobulinemic glomerulonephritis in thymic stromal lymphopoietin transgenic mice.

Authors:  S Taneda; S Segerer; K L Hudkins; Y Cui; M Wen; M Segerer; M H Wener; C G Khairallah; A G Farr; C E Alpers
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

4.  Podocyte expression of the CDK-inhibitor p57 during development and disease.

Authors:  K Hiromura; L A Haseley; P Zhang; T Monkawa; R Durvasula; A T Petermann; C E Alpers; P Mundel; S J Shankland
Journal:  Kidney Int       Date:  2001-12       Impact factor: 10.612

5.  Roles of SLC/CCL21 and CCR7 in human kidney for mesangial proliferation, migration, apoptosis, and tissue homeostasis.

Authors:  Bernhard Banas; Markus Wörnle; Thorsten Berger; Peter J Nelson; Clemens D Cohen; Matthias Kretzler; Jochen Pfirstinger; Matthias Mack; Martin Lipp; Hermann-Josef Gröne; Detlef Schlöndorff
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

6.  Roles of toll-like receptors in C-C chemokine production by renal tubular epithelial cells.

Authors:  Naotake Tsuboi; Yasunobu Yoshikai; Seiichi Matsuo; Takeshi Kikuchi; Ken-Ichiro Iwami; Yoshiyuki Nagai; Osamu Takeuchi; Shizuo Akira; Tetsuya Matsuguchi
Journal:  J Immunol       Date:  2002-08-15       Impact factor: 5.422

7.  Bacterial CpG-DNA aggravates immune complex glomerulonephritis: role of TLR9-mediated expression of chemokines and chemokine receptors.

Authors:  Hans-Joachim Anders; Bernhard Banas; Yvonne Linde; Lars Weller; Clemens D Cohen; Matthias Kretzler; Stefan Martin; Volker Vielhauer; Detlef Schlöndorff; Hermann-Josef Gröne
Journal:  J Am Soc Nephrol       Date:  2003-02       Impact factor: 10.121

8.  Deletion of the fcgamma receptor IIb in thymic stromal lymphopoietin transgenic mice aggravates membranoproliferative glomerulonephritis.

Authors:  Anja S Mühlfeld; Stephan Segerer; Kelly Hudkins; Matthew D Carling; Min Wen; Andrew G Farr; Jeffrey V Ravetch; Charles E Alpers
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

9.  Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice.

Authors:  Hans-Joachim Anders; Volker Vielhauer; Vaclav Eis; Yvonne Linde; Matthias Kretzler; Guillermo Perez de Lema; Frank Strutz; Stefan Bauer; Mark Rutz; Hermann Wagner; Hermann-Josef Gröne; Detlef Schlöndorff
Journal:  FASEB J       Date:  2004-01-20       Impact factor: 5.191

Review 10.  Kidney and liver involvement in cryoglobulinemia.

Authors:  Fabrizio Fabrizi; Patrizia Colucci; Claudio Ponticelli; Francesco Locatelli
Journal:  Semin Nephrol       Date:  2002-07       Impact factor: 5.299

View more
  89 in total

Review 1.  Immune system in renal injury and repair: burning the candle from both ends?

Authors:  Michael S Goligorsky
Journal:  Pharmacol Res       Date:  2008-06-08       Impact factor: 7.658

Review 2.  Drug discovery in focal and segmental glomerulosclerosis.

Authors:  Nick Pullen; Alessia Fornoni
Journal:  Kidney Int       Date:  2016-04-23       Impact factor: 10.612

Review 3.  Beyond tissue injury-damage-associated molecular patterns, toll-like receptors, and inflammasomes also drive regeneration and fibrosis.

Authors:  Hans-Joachim Anders; Liliana Schaefer
Journal:  J Am Soc Nephrol       Date:  2014-04-24       Impact factor: 10.121

4.  Hyperglycemia induces Toll like receptor 4 expression and activity in mouse mesangial cells: relevance to diabetic nephropathy.

Authors:  Harmeet Kaur; Alexander Chien; Ishwarlal Jialal
Journal:  Am J Physiol Renal Physiol       Date:  2012-08-08

Review 5.  How the Innate Immune System Senses Trouble and Causes Trouble.

Authors:  Takashi Hato; Pierre C Dagher
Journal:  Clin J Am Soc Nephrol       Date:  2014-11-20       Impact factor: 8.237

Review 6.  Immunology of idiopathic nephrotic syndrome.

Authors:  Manuela Colucci; Giorgia Corpetti; Francesco Emma; Marina Vivarelli
Journal:  Pediatr Nephrol       Date:  2017-04-27       Impact factor: 3.714

7.  Lipopolysaccharide induces inducible nitric oxide synthase-dependent podocyte dysfunction via a hypoxia-inducible factor 1α and cell division control protein 42 and Ras-related C3 botulinum toxin substrate 1 pathway.

Authors:  Ahmad K Mashmoushi; Jim C Oates
Journal:  Free Radic Biol Med       Date:  2015-03-09       Impact factor: 7.376

8.  Requirement for TLR2 in the development of albuminuria, inflammation and fibrosis in experimental diabetic nephropathy.

Authors:  Jin Ma; Huiling Wu; Cathy Y Zhao; Usha Panchapakesan; Carol Pollock; Steven J Chadban
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

9.  Urinary Fibrinogen as a Predictor of Progression of CKD.

Authors:  Hongtian Wang; Chunxia Zheng; Yinghui Lu; Qi Jiang; Ru Yin; Ping Zhu; Minlin Zhou; Zhihong Liu
Journal:  Clin J Am Soc Nephrol       Date:  2017-09-13       Impact factor: 8.237

10.  Cross-talk between TLR4 and FcgammaReceptorIII (CD16) pathways.

Authors:  Daniel Rittirsch; Michael A Flierl; Danielle E Day; Brian A Nadeau; Firas S Zetoune; J Vidya Sarma; Clement M Werner; Guido A Wanner; Hans-Peter Simmen; Markus S Huber-Lang; Peter A Ward
Journal:  PLoS Pathog       Date:  2009-06-05       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.